ReviewOncoTargets and therapy2021

Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib.

James Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.